Latest filingSep 02, 2026Most recent Form 4
GNLX
GENELUX Corp
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$14.6M3 sells
Net open-market-$14.6M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period3transactions
- S · Open-market sells · dominant3 · 100%
Activity by reported role
A joint filing can contribute to multiple roles3transactions
- CSO · dominant1 · 33%
- CTO1 · 33%
- PRES1 · 33%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (3)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeYu YongCommon Stock · Direct
258,688Aug 31, 2026
Zindrick ThomasCommon Stock · Direct
1,226,427Aug 31, 2026
Cappello JosephCommon Stock · Direct
318,480Aug 31, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- ZT-$91.9k
- CJ-$28.1k
- YY-$26.7k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
GNLX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| GNLX | Cappello Joseph | CTO | sale | 10.2k | -$2.81M | S | — | — | 09/02 | 08/31 |
| GNLX | Zindrick Thomas | PRES | sale | 34.4k | -$9.18M | S | — | — | 09/02 | 08/31 |
| GNLX | Yu Yong | CSO | sale | 9.68k | -$2.66M | S | — | — | 09/02 | 08/31 |
GENELUX Corp Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at GENELUX Corp?
Cappello Joseph, Zindrick Thomas, Yu Yong.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Cappello Joseph reported a sale on Aug 31, 2026 valued at $2.81M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $146,669.70. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.